Shares of Intuitive Surgical (NASDAQ:ISRG) closed higher 3.63 percent higher on Monday, one day before the company is to release its fiscal third-quarter earnings report. The jump is attributable in part to JPMorgan upgrading Intuitive Surgical’s stock to Outperform.
The upgrade came in spite of a recent downturn in domestic prostate surgeries, which the firm believes can be more than made up for by increased opportunities in other cancer areas.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
“We find the risk/reward increasingly compelling, in light of the meaningful opportunities emerging in partial nephrectomy, cholecystectomy, colorectal surgery, and other areas – which, collectively, should more than offset the [prostate surgery] softness and drive upside to Street estimates for the next several years,” said JPMorgan analyst Tycho Peterson.
The firm raised earnings per share estimates for the 2012 fiscal year to $14.85 per share, up from $11.57. Intuitive Surgical’s third quarter earnings will be released on Tuesday.